Ketamine Hydrochloride 25021-0684-05
- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- July 15, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA216809
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ketamine Hydrochloride | 100 mg/mL |
Drug Class
General Anesthesia [PE]General Anesthetic [EPC]
Selected Package
25021-0684-05Selected10 VIAL in 1 CARTON (25021-684-05) / 5 mL in 1 VIAL